EuroPCR 2021 Hotlines / Late-Breaking Trials: CENTURY JSV, SORT OUT IX, OUTDES, Epic02-RANGO, PIONEER III, and more!

Session comprising selected EuroPCR 2021 Hotlines & Late-Breaking Trials submissions

Y. Ahmad, A. Baumbach, L.O. Jensen, M. Mamas, A. Perez de Prado, K. Shishido, U. Wickramarachchi

Summary

Find out more about various studies & registries in stents:

First machine learning derived risk score for target lesion failure
Ultrathin versus Conventional Second-Generation DES: Meta-Analysis of RCTs
Five-year outcomes after coronary stenting of small vessels - CENTURY JSV study
2-year outcomes of the randomized SORT OUT IX Trial
Outcomes of drug coated balloons versus drug eluting stents in all vessel sizes
Angiolite safety and efficacy evaluation in daily practice non-selected patients
PIONEER III: Results with the SUPREME DES in complex lesions

Presentations available when logged in:

First machine learning derived risk score for target lesion failure
Ultrathin versus Conventional Second-Generation DES: Meta-Analysis of RCTs
Five-year outcomes after coronary stenting of small vessels -CENTURY JSV study-
2-year outcomes of the randomized SORT OUT IX Trial
Outcomes of drug coated balloons versus drug eluting stents in all vessel sizes
Angiolite safety and efficacy evaluation in daily practice non-selected patients
PIONEER III: Results with the SUPREME DES in complex lesions

Your free My PCR account will enable you to: